Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 6
- International Regulation
Cannabis Industry Council Releases Global Guide for Patients Travelling with Medical Cannabis
The UK’s Cannabis Industry Council (CIC) has published a new comprehensive guide for patients travelling with prescribed medical cannabis in the wake of a series of reported incidents involving both airlines and border control authorities.
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Medical Cannabis
The Right Reforms, the Wrong Narrative: Why the Medical Cannabis Debate Is Missing Half the Picture
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
- Medical Cannabis
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
- UK & Europe
Züri Can Extended By Two Years As Results Point To Black Market Deterrence
Zurich’s municipal parliament has voted to extend its flagship adult-use cannabis pilot, Züri Can, by a further two years to October 2028, and to provide an additional CHF 800,000 in funding, in a 101-13 vote that laid bare the fault lines in Swiss cannabis politics.
- Medical Cannabis
Oliver’s Law: The Campaign That Could Reshape UK Cannabis Prescribing
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis contributed to a death in the country.
- CBD Market
Has UK’s ‘Brexit Reset’ Derailed 5-Year CBD Approval Battle?
The UK CBD industry’s long and hard-fought battle to become the first in the world to receive official regulatory approval looks likely to have been in vain, as the Food Standards Agency (FSA) raises serious questions over whether the process can deliver before it is overtaken by an EU alignment initiative.
- US & Canada
‘How Does the DEA Plan to Reschedule Without a Judge?’ – Lawmaker Demands Answers on Cannabis Rescheduling Chaos
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on the administration’s radio silence.
- CBD Market
White House to Meet With Cannabis Industry On Overdue CBD Enforcement Policy
Six weeks after the US Food and Drug Administration (FDA) failed to meet its 90-day deadline to clarify which cannabinoids will be impacted by a controversial incoming ban, the White House has scheduled three meetings with industry executives to discuss the matter.
- Public Markets
US Cannabis Companies Could Finally Get Access to NASDAQ and Financial Services Under New Bill
Bipartisan lawmakers have reintroduced a bill to the House of Representatives that would provide a pathway for cannabis businesses to list on the US stock exchange, accessing the institutional capital they sorely need.
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
